Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AMRN Amarin > Financial Statement > Income statement
AMRN Amarin
1.170
-0.020-1.68%
Post Mkt Price
1.1700.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
-36.72% 89.88M -38.87% 94.44M -33.44% 94.63M -5.03% 583.19M
Operating revenue
-36.72% 89.88M -38.87% 94.44M -33.44% 94.63M -5.03% 583.19M
Cost of revenue
-10.57% 27.02M 58.02% 50.81M -21.49% 22.24M -7.70% 121.33M
Gross profit
-43.79% 62.86M -64.34% 43.63M -36.41% 72.39M -4.30% 461.86M
Operating expense
-41.77% 64.51M -15.24% 96.25M -12.57% 100.7M -12.87% 437.64M
Selling and administrative expenses
-42.95% 58.75M -18.95% 86.89M -14.32% 90.65M -11.87% 408.33M
-Selling and marketing expense
-52.22% 32.44M -27.17% 53.13M -6.48% 62.25M -24.01% 266.47M
-General and administrative expense
-25.00% 26.3M -1.42% 33.76M -27.62% 28.4M 25.91% 141.86M
Research and development costs
-26.28% 5.77M 47.18% 9.36M 7.19% 10.05M -24.77% 29.31M
Operating profit
-258.45% -1.65M -699.78% -52.62M -2,026.75% -28.31M 223.22% 24.22M
Net non-operating interest income expense
360.12% 750K 1.05% 288K -56.90% 203K -52.48% 1.09M
Non-operating interest income
34.89% 750K -8.57% 288K -61.33% 203K -75.11% 1.22M
Non-operating interest expense
-- -- -- -- -- -- -95.05% 129K
Other net income (expense)
78.96% -2.98M -6,427.75% -12.47M -73.24% -246K -13,579.81% -14.02M
Special income (charges)
75.25% -3.49M -- -10.21M -- -- -- -13.72M
-Less:Restructuring and merger&acquisition
-75.25% 3.49M -- 10.21M -- -- -- 13.72M
Other non- operating income (expenses)
996.49% 511K -1,080.63% -2.26M -73.24% -246K -390.38% -302K
Income before tax
70.05% -3.88M -830.79% -64.8M -2,729.34% -28.35M 165.44% 11.29M
Income tax
583.15% 1.26M 386.97% 5.16M 414.90% 3.21M 378.12% 3.56M
Net income
60.92% -5.14M -995.95% -69.96M -1,841.14% -31.56M 142.94% 7.73M
Net income continuous Operations
60.92% -5.14M -995.95% -69.96M -1,841.14% -31.56M 142.94% 7.73M
Minority interest income
Net income attributable to the parent company
60.92% -5.14M -995.95% -69.96M -1,841.14% -31.56M 142.94% 7.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.92% -5.14M -995.95% -69.96M -1,841.14% -31.56M 142.94% 7.73M
Basic earnings per share
66.67% -0.01 -1,000.00% -0.18 -1,841.75% -0.08 140.00% 0.02
Diluted earnings per share
66.67% -0.01 -1,000.00% -0.18 -1,841.75% -0.08 140.00% 0.02
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
CEO: Mr. Karim Mikhail
Market: NASDAQ
Listing Date: 04/01/1993
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist